Publications by authors named "Kenneth A Kern"

19Publications

Trial Design and Efficacy Thresholds for Granting Breakthrough Therapy Designation in Oncology.

Authors:
Kenneth A Kern

J Oncol Pract 2016 08 26;12(8):e810-7. Epub 2016 Jul 26.

Pfizer, San Diego, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.012161DOI Listing
August 2016

PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparib.

Clin Pharmacol Drug Dev 2015 03 26;4(2):89-98. Epub 2015 Jan 26.

Northern Institute for Cancer Research, Medical School, Newcastle University, Newcastle Upon Tyne, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.176DOI Listing
March 2015

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.

Breast 2013 Oct 17;22(5):650-6. Epub 2013 Aug 17.

Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.037DOI Listing
October 2013

Phase II open-label study of sunitinib in patients with advanced breast cancer.

Breast Cancer Res Treat 2012 Dec 17;136(3):759-67. Epub 2012 Oct 17.

The Sarah Cannon Research Institute and Tennessee Oncology, Suite 110, 250 25th Ave. North, Nashville, TN 37203, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-012-2285
Web Search
http://link.springer.com/10.1007/s10549-012-2285-0
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2285-0DOI Listing
December 2012

An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer.

Breast 2012 Dec 27;21(6):716-23. Epub 2012 Sep 27.

Medical Oncology & Translational Research, Jules Bordet Institute, Boulevard de Waterloo, 125, 1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2012.09.002DOI Listing
December 2012

Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.

Authors:
Kenneth A Kern

J Am Coll Surg 2002 Oct;195(4):467-75

Department of Surgery, Hartford Hospital and University of Connecticut School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1072-7515(02)01312-1DOI Listing
October 2002